HTO vs SRPT · P/E 20, rev $800.6M vs rev $1.13B
H2O America (HTO) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
H2O America (HTO) is a utilities - regulated water company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported HTO revenue for 2025-12-31 was $800.6M. Net income was $102.6M. Revenue was up 7.0% from 2024-12-31 to 2025-12-31. HTO currently screens at market cap $2.40B and trailing P/E 19.7.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
HTO currently screens at market cap $2.40B and trailing P/E 19.7. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the HTO and SRPT stock pages for the full models.
Not investment advice.